These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14067498)

  • 1. [USE OF RACEMIC 1-(M-HYDROXYPHENYL)-2-ETHYLAMINOETHANOL HC1 CONSIDERED AS A CARDIOVASCULAR ANALEPTIC IN COLLAPSE AND SEVERE HYPOTENSION IN THE COURSE OF MYOCARDIAL INFARCTION].
    FAIVRE G; GILGENKRANTZ JM; CHERRIER F; ROYER R; REBEIX G
    Ann Med Nancy; 1963 Jun; 2():993-1002. PubMed ID: 14067498
    [No Abstract]   [Full Text] [Related]  

  • 2. THE USE AND ABUSE OF VASOPRESSORS.
    ROSENBERG R; HELLER F; SADOVE MS
    Surg Clin North Am; 1964 Feb; 44():155-71. PubMed ID: 14116101
    [No Abstract]   [Full Text] [Related]  

  • 3. CLINICAL MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION.
    HURLBURT FW; GILLIS JG; KAVANAGH-GRAY D; PALMER RA; SHALLARD B; TRAYNOR JA
    Can Med Assoc J; 1965 Aug; 93(9):398-403. PubMed ID: 14339304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HEMODYNAMIC EFFECTS OF PRESSOR AGENTS IN SEPTIC AND MYOCARDIAL INFARCTION SHOCK.
    SMULYAN H; CUDDY RP; EICH RH
    JAMA; 1964 Oct; 190():188-94. PubMed ID: 14246588
    [No Abstract]   [Full Text] [Related]  

  • 5. TREATMENT OF CARDIOGENIC SHOCK AND VASOPRESSOR DEPENDENCY WITH INTRAVENOUS METHYLPHENIDATE (RITALIN).
    BRACHFELD J; MYERSON RM
    Am J Cardiol; 1965 May; 15():665-7. PubMed ID: 14285150
    [No Abstract]   [Full Text] [Related]  

  • 6. [Indications, in anesthesia-resuscitation, for various analeptics during per-operative hypotension].
    Viars P
    Anesth Analg (Paris); 1969; 26(5):733-41. PubMed ID: 4391674
    [No Abstract]   [Full Text] [Related]  

  • 7. NEWER AGENTS IN THE TREATMENT OF SHOCK.
    MARSHALL RJ; DARBY TD
    Med Clin North Am; 1964 Mar; 48():311-28. PubMed ID: 14149237
    [No Abstract]   [Full Text] [Related]  

  • 8. [PLACE OF A VASOPRESSOR DRUG (EFFORTIL) IN MEDICAL RESUSCITATION].
    LARCAN A; VERT P
    Ann Med Nancy; 1964; 3():874-86. PubMed ID: 14205394
    [No Abstract]   [Full Text] [Related]  

  • 9. BACTEREMIC SHOCK--A MEDICAL EMERGENCY.
    RUEDY J; DIRKS JH; CAMERON DG
    Can Med Assoc J; 1963 Nov; 89(21):1059-63. PubMed ID: 14079124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [EFFECT OF 48-80 ON ANAPHYLACTIC AND PEPTONE SHOCK IN THE DOG].
    CSABA B; SZILAGYI T; DAMJANOVICH S; KOEVER A
    Kiserl Orvostud; 1963 Oct; 15():478-84. PubMed ID: 14092921
    [No Abstract]   [Full Text] [Related]  

  • 11. THE PATHOGENESIS AND TREATMENT OF SEPTIC SHOCK.
    LANSING AM
    J Ky Med Assoc; 1964 Aug; 62():590-5. PubMed ID: 14180667
    [No Abstract]   [Full Text] [Related]  

  • 12. ADRENOCORTICOIDS IN THE MANAGEMENT OF SHOCK.
    SAMBHI MP; WEIL MH; UDHOJI VN; SHUBIN H
    Int Anesthesiol Clin; 1964 Feb; 2():421-33. PubMed ID: 14125019
    [No Abstract]   [Full Text] [Related]  

  • 13. Heart force effects of sympathomimetic amines as a basis for their use in shock accompanying myocardial infarction.
    GAZES PC; GOLDBERG LI; DARBY TD
    Circulation; 1953 Dec; 8(6):883-92. PubMed ID: 13106909
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of a pressor agent in shock accompanying myocardial infarction.
    COHEN IR; BUTTERWORTH JS
    N Y State J Med; 1952 Aug; 52(16):2038-9. PubMed ID: 13002786
    [No Abstract]   [Full Text] [Related]  

  • 15. The treatment of myocardial infarction with shock; advantages and disadvantages of use of levophed.
    SEGAL JA
    Conn State Med J; 1955 Jan; 19(1):14-7. PubMed ID: 13219922
    [No Abstract]   [Full Text] [Related]  

  • 16. [Problems concerning the treatment and hospitalization of patients with myocardial infarct complicated by collapse].
    SHAPIRO LB; POPOV VG; ROMADIN NA; SMETNEV AS; BELKIN VS
    Sov Med; 1963 Jan; 26():18-21. PubMed ID: 13976835
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical trials with 4-methyl-2-aminopyridine camphorsulfonate in the shock from recent infarct].
    BONAZZA A
    Gazz Med Ital; 1962 Jul; 121():189-94. PubMed ID: 13968716
    [No Abstract]   [Full Text] [Related]  

  • 18. [Central venous pressure in control of cardiogenic shock].
    Gavrilescu S; Cotoi S; Riviş I
    Med Interna (Bucur); 1968 Nov; 20(11):1361-8. PubMed ID: 5731992
    [No Abstract]   [Full Text] [Related]  

  • 19. Shock accompanying myocardial infarction: treatment with pressor amines amines.
    HELLERSTEIN HK; BROFMAN BL; CASKEY WH
    Am Heart J; 1952 Sep; 44(3):407-27. PubMed ID: 14952464
    [No Abstract]   [Full Text] [Related]  

  • 20. THE TREATMENT OF SHOCK ACCOMPANYING MYOCARDIAL INFARCTION.
    BERNSTEIN A; ROTHFELD EL; ROBINS B; COHEN F; SIMON F
    Angiology; 1963 Nov; 14():559-63. PubMed ID: 14075028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.